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Abstract We recently identified a novel human protein kinase, 
p160 ROCK, as a putative downstream target of the small 
GTPase Rho. Using the human ROCK cDNA as a probe, we 
isolated cDNA of two distinct, highly related sequences from 
mouse libraries. One encoded a mouse counterpart of human 
ROCK (ROCK-I), and the other encoded a novel ROCK-related 
kinase (ROCK-II). Like ROCK/ROCK-I, ROCK-II also bound 
to GTP-Rho selectively. ROCK-I mRNA was ubiquitously 
expressed except in the brain and muscle, whereas ROCK-II 
mRNA was expressed abundantly in the brain, muscle, heart, 
lung and placenta. These results suggest hat at least two ROCK 
isoforms are present in a single species and play distinct roles in 
Rho-mediated signalling pathways. 
Key words: Rho GTPase; Signal transduction; Protein 
sedne/threonine kinase; cDNA cloning; Gene expression 
1. Introduction 
The small GTPase Rho controls various cellular processes 
by shuttling between the inactive GDP-bound form and the 
active GTP-bound form. Rho is a key regulator of stimulus- 
ex oked cell adhesion and motility, enhancement of contractile 
responses, cytokinesis and transcriptional regulation through 
the activation of serum response factor [1]. Rho apparently 
mediates multiple intracellular signalling pathways, and is 
li~:ely to fulfil these actions by activating various downstream 
targets. We and others have demonstrated that protein phos- 
pilorylation by tyrosine kinases and serine/threonine kinases is 
ilwolved in Rho-activated signalling [2-5]. The direct target 
molecules of Rho, however, remained unclarified. Using the 
y~ast wo hybrid system with Val14-Rho as a bait or using the 
li!,and overlay assay with [35S]GTPTS-RhoA, we recently iden- 
tiffed five putative target molecules. They can be classified into 
two groups. One includes a serine/threonine kinase PKN, and 
two novel non-kinase proteins, rhophilin and rhotekin [6,7]. 
q aese molecules possess a homologous Rho-binding motif of 
about 70 amino acids in length. The other is composed of a 
novel non-kinase molecule, citron, and a newly identified ki- 
nase, pl60 ROCK [8,9]. They show Rho-binding sequences 
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different from the motif seen in the first group and share 
general structural characteristics. 
pl60 ROCK is a protein serine/threonine kinase which has 
a kinase domain in the amino-terminus, an about 600 amino- 
acid-long coiled-coil forming region in the middle, and a 
pleckstrin homology region and a Cys-rich zinc finger-like 
motif in the carboxyl-terminus. The kinase domain of 
ROCK shows a significant sequence homology to myotonic 
dystrophy protein kinase (MD-PK) [9,10]. In this study, we 
screened mouse cDNA libraries using human pl60 ROCK 
cDNA as a probe, and identified two related protein kinases. 
Our results indicate that ROCK protein kinases constitute a
distinct kinase family composed of at least two isoforms. 
2. Materials and methods 
2.1. Isolation and sequencing ofmouse ROCK-I and ROCK-H 
Two cDNA fragments of human pl60 ROCK were prepared as 
probes. The cDNA fragment coding for the amino-terminal kinase 
domain of human pl60 ROCK (nucleotides 220-999 in the cDNA 
sequence U43195 in GenBank/EMBL Data Bank) was amplified by 
PCR using the cDNA fragment of human pl60 ROCK as a template 
[9]. The 5]0eI fragment of human pl60 ROCK cDNA encoding the 
carboxyl region (nucleotide 1094-4057 in U43195) was also prepared 
as a probe. These two probes were used to isolate cDNA fragments 
that cover the entire region of mouse ROCK. cDNA prepared from 
mouse mbryo mRNA (El 1.5 days) was constructed in bacteriophage 
~.gtl0 as previously described [11]. Approx. 5 x 10 ~ plaques each from 
this mouse mbryo cDNA library and from the mouse heart library in 
~,gtl0 (Clontech) were transferred to nylon membranes (Colony 
Plaque Screen, Du Pont NEN). Hybridization was carried out at 
55°C in a solution containing 1 M sodium chloride, 1%o SDS, 50 
mM Tris-Cl (pH 7.5), 200 gg/ml heat-denatured salmon sperm 
DNA and 32P-labelled probes. The membranes were washed serially, 
with a final wash in 2 × SSC, 0.1% SDS at 55°C. The positive clones 
were purified, and restriction fragments of the cDNA inserts were 
subcloned into pBluescript SK(+). DNA sequencing was performed 
by the dideoxy-mediated chain termination method, using an ALFred 
automated DNA sequencer system (Pharmacia). The sequences were 
confirmed by reading both DNA strands. 
2.2. Ligand overlay assay 
The HinclI-XbaI fragment of clone no. 87 corresponding to nucleo- 
tide 2452-3870 of mouse p160 ROCK-II (U58513 in GenBank/EMBL 
Data Bank) was subcloned to the plasmid pQE (pQE87HX). E. coli 
JMI09 (Toyobo) was transformed with pQE87HX and was grown to 
an Ar00 of 0.8. After the addition of isopropyl [3-D-thiogalactoside, th  
culture was continued for another 24 h at 20°C. Cells were lysed with 
8 M urea containing 0.1 M sodium phosphate and 10 mM Tris-C1 
(pH 8.0) at 25°C for 1 h. After centrifugation at 12000×g for 10 min, 
the supernatant was recovered and incubated with Ni-NTA resin 
(Qiagen) at 25°C for 1 h. The resin was washed with 8 M urea con- 
taining 0.1 M sodium phosphate and 10 mM Tris-C1 (pH 6.3), and 
boiled in Laemmli sample buffer for 5 min. The extracted His-tagged 
proteins were subjected to SDS-PAGE on 18% polyacrylamide g ls, 
transferred onto nitrocellulose membranes (Scbleicher & Schuell), de- 
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natured and renatured on the membranes. Recombinant human 
RhoA/GST fusion protein was prepared and loaded with either 
[35S]GTP'~S or [35S]GDP[~S, as previously described [9]. The mem- 
branes were then incubated with 8.1 nM 3~S-labelled Rho in the over- 
lay assay buffer. The membranes were washed as previously described 
[9], and exposed to X-ray film. 
2.3. Probe preparation and Northern blotting analyses 
cDNA probes for Northern blotting analyses were prepared by 
PCR using isolated cDNA clones as templates. To prepare cDNA 
fragments corresponding to the kinase domain [12] (Fig. 1), oligonu- 
cleotide primers were synthesized: 5'-TAT GAA GTG GTA AAG 
GTA ATC GGC-3' (sense for ROCK-I), 5'-GAA GAA GAG ATG 
ACG TTT GAT TTC-3' (antisense for ROCK-I), 5'-TAT GAT GTT 
GTA AAA GTT ATT GGA-3' (sense for ROCK-II) and 5'-AAA 
GAA AGG ATG CTG TTT GAT TTC-Y (antisense for ROCK- 
II). PCR was performed under standard conditions [13]. Amplified 
789 bp fragments were subcloned into the plasmid pCR2.1 (Invitro- 
gen), and the sequences of the inserts were confirmed. Rat GAPDH 
cDNA fragment [14] was used as an internal control. These probes 
were labelled by the random priming method with [a-32P]dCTP [13]. 
Specific activity was approx. 1 × 109 cpm/gtg DNA. Total RNA was 
extracted from various tissues obtained from 14-week-old male 
BALB/c mice, whole embryos (El0 and El7 days) and the placenta 
(E 17 days), using the AGPC method [13]. Poly(A) + RNA was purified 
using an oligo(dT) latex (oligoTEX dT30 Super, Daiichi Chemical). 
3 pg aliquots of poly(A) + RNA were size-fractionated by electrophor- 
esis on 1.0% agarose-formaldehyde gels and transferred toBiodyne A 
nylon membranes (Pall). The membranes were prehybridized at 42°C 
for 12 h in a solution containing 50% formamide, 5XSSPE, 5xDen- 
hardt's olution, 0.1% SDS, and 100 ~tg/ml heat-denatured salmon 
sperm DNA. Hybridization was performed in the same solution in- 
cluding heat-denatured a ioprobes at42°C for 24 h. The membranes 
were washed serially, with a final wash in 0.1 xSSC, 0.1% SDS at 
65°C, and subjected toanalysis using a BAS 2000 Bioimage analyzer 
(Fuji Film). 
3. Results 
3.1. cDNA cloning and characterization of  mouse pl60 
ROCK-I and ROCK-H 
We screened mouse embryo and heart libraries using hu- 
man pl60 ROCK cDNA as a probe. Two cDNAs were used 
as probes. One corresponded to the amino-terminal kinase 
domain of human pl60 ROCK, and the other to the coiled- 
coil forming region and carboxyl-terminal region. Hybridiza- 
tion was separately performed using each probe. More than 
100 positive clones were obtained by this procedure. Sequence 
analyses were first performed on clones hybridized with the 
probe for the kinase domain, and then extended to clones 
showing overlapping sequences. Two composite cDNA se- 
quences were obtained, and they encoded related but distinct 
protein kinases. 
A 6181-nucleotide cDNA sequence identified by the analy- 
sis of five clones, nos. 2, 7, 8, 13 and 119, contained a 4062- 
nucleotide open reading frame, which encoded a 1354-amino- 
acid protein with a relative molecular mass of 158 168 Da 
(Fig. 1A). The putative initiation site was preceded by an 
in-frame termination codon. The nucleotide sequence of the 
open reading frame and deduced amino acid sequence were 
highly homologous to those of human pl60 ROCK (92.0 and 
96.5%, respectively). In addition, functional domains observed 
in human pl60 ROCK were conserved in this mouse se- 
quence. A protein serine/threonine kinase domain was present 
in the amino-terminal region (amino acids 76-338) [12], and a 
coiled-coil forming region predicted by the algorithm of Lu- 
pas et al. [15] (amino acids 460-1068) followed. A pleckstrin 
homology domain [16] and a cysteine-rich zinc finger motif 
[17] exist in the carboxyl-terminal region (Fig. 1B). We, there- 
fore, concluded that this represents a mouse counterpart of 
human pl60 ROCK, and named it mouse pl60 ROCK-I. 
The second sequence identified by clones nos. 22, 24, 87 and 
115 was 5743 nucleotide long, and contained a 4164-nucleo- 
tide open reading frame encoding 1388-amino-acid protein 
with a relative molecular mass of 160583 Da (Fig. 1A). Its 
putative initiation site was also preceded by an in-frame ter- 
mination codon. The nucleotide and amino acid sequence 
homologies to human pl60 ROCK were 60.9 and 65.3%, re- 
spectively. While they are much lower than those of mouse 
ROCK-I, all the functional domains present in human pl60 
ROCK were also conserved in this molecule (Fig. I B). The 
kinase domains howed particularly high homology between 
mouse ROCK-I and ROCK-II (92.0% in the amino acid se- 
quence). These results indicate that this molecule is a protein 
kinase closely related to mouse ROCK-I, and we designated it 
mouse pl60 ROCK-II. 
We previously demonstrated that human pl60 ROCK spe- 
cifically binds to RhoA in a GTP-dependent manner [9]. De- 
letion and mutation analyses coupled with the ligand overlay 
assay and the yeast two hybrid assay identified amino acids 
934-1015 of human pl60 ROCK as the Rho-binding domain 
(Fujisawa et al., unpublished observation). This part of the 
sequence was highly conserved in mouse ROCK-I, whereas 
the conservation i ROCK-II was approx. 55%. In order to 
demonstrate he association of Rho with ROCK-II, we pre- 
pared a recombinant protein containing the corresponding 
region of mouse ROCK-II in E. coli, and examined its binding 
to human RhoA/GST fusion protein loaded with [35S]GTPTS 
or [zSS]GDPI3S. As seen in Fig. 2, this truncated protein of 
mouse ROCK-II selectively bound to the GTP-bound form of 
RhoA. 
3.2. Northern blotting analysis of mouse ROCK-I and 
ROCK-H 
Gene expression of ROCK-I and ROCK-II in various 
mouse tissues was examined by Northern blotting analyses 
using cDNA corresponding to the kinase domains as probes. 
A 6.6 kb mRNA band of ROCK-I was detected in all the 
tissues and whole fetuses (Fig. 3A). Mouse ROCK-I mRNA 
was abundantly expressed in the heart, lung, liver, stomach, 
spleen, kidney, testis, placenta nd fetus, but much less in the 
brain and skeletal muscle. An additional transcript of 6.0 kb 
was observed in the testis. Expression of mRNA for mouse 
ROCK-II showed distinct pattern from that of mouse ROCK- 
I (Fig. 3B). Three major transcripts of 7.6, 6.6 and 5.6 kb were 
detected. Expression of mouse ROCK-II mRNA was high in 
the brain, heart, lung, muscle, placenta nd fetus, and was 
relatively low in the liver, stomach, spleen, kidney and testis. 
4. Discussion 
In this study, two protein kinases, ROCK-I and ROCK-II, 
were isolated as mouse homologues of human pl60 ROCK. 
The alignments of their functional domains are identical, as 
presented in Fig. 1B and as reported previously [9]. The amino 
acid sequence of the kinase domain of mouse ROCK-I is 
completely identical to that of human pl60 ROCK, which 
shows serine/threonine kinase activity in vitro and in vivo 
[9]. The amino acid sequences of mouse ROCK-I and 
ROCK-II are 92% homologous and well consistent with the 
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F g. 1. Deduced amino acid sequences of mouse ROCK-I and ROCK-II (A) and schematic representation of their predicted functional domains 
(10. (A) Deduced amino acid sequences of mouse ROCK-I and ROCK-II are aligned according to their homology. Amino acids are numbered 
a E the end of each line. Horizontal bars in the sequences represent insertions to maximize the homology of the aligned sequences. Vertical lines 
r, present identical amino acid residues. The 16th codon (GCC, alanine), identified in clone no. 22 and shown here, was substituted to (ACC, 
tl reonine) in two other clones of ROCK-II (nos. 115, 116). The accession numbers of the cDNA sequences of mouse ROCK-I and ROCK-If 
i~: the GenBank/EMBL Data Bank are U58512 and U58513, respectively. (B) Predicted functional domains are shown by boxes. Kinase do- 
main, protein serine/threonine kinase domain; coiled-coil region, amphipathic a-helix (coiled-coil forming region); PH (I-VI), pleckstrin homol- 
ogy domain (I-V[); Cys-rich, cysteine-rich zinc finger-like domain. Numbers represent those of amino acid residues. The Rho-binding domain 
k entitled in human p160 ROCK corresponds to amino acids 934-1015 of mouse ROCK-I. 
mot i f  conserved among various protein serine/threonine ki- 
nases [12]. In addition, the amino acid sequence of  the Rho- 
btnding domain of  human ROCK is well conserved in mouse 
ROCK-I, and the recombinant ROCK-I I  protein containing 
the corresponding region showed GTP-dependent binding to 
RhoA. These results suggest that mouse ROCK-I  and ROCK- 
II act as protein serine/threonine kinases downstream of Rho 
in cellular signalling. 
Among the functional domains, the {x-helical, coiled-coil 
forming structure is most diverse between ROCK-I  and 
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Fig. 2. GTP-dependent binding of recombinant RhoA to mouse 
ROCK-II fragment. Fragment of mouse ROCK-II (amino acids 
818-1290) was prepared as a His-tagged protein, and subjected to li- 
gand overlay assay using [3SS]GDPI3S- or [35S]GTPTS-loaded GST- 
human RhoA. pQE, pQE vector alone; pQE87HX, pQE containing 
the HinclI/XbaI fragment of no. 87 clone of mouse ROCK-II 
cDNA; CBB, Coomassie brilliant blue staining. Positions of molec- 
ular size markers are shown on the left (in kDa). 
ROCK-II. A coiled-coil forming region is supposed to dimer- 
ize or interact with other amphipathic o-helical proteins, 
which leads to functional regulation and intracellular localiza- 
tion of these proteins [18]. The difference in the coiled-coil 
forming sequence of ROCK-I and ROCK-II  suggests a pos- 
sibility that they may have different localization and play dis- 
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tinct roles in the cell. MD-PK, which contains a kinase do- 
main and a coiled-coil forming region homologous to ROCK 
[9,10], is specifically localized to the myotendenous junction of 
skeletal muscle, the dense plaques of smooth muscle and the 
intercalated disc of cardiac muscle [19], in which muscle fibers 
fuse to the membranes and many focal adhesion proteins 
accumulate. ROCK may also be present in related intracellu- 
lar compartments and be involved in Rho-mediated cytoskel- 
etal regulation. 
Recently, Leung et al. [20] and Matsui et al. [21] identified 
rat and bovine protein kinases as putative Rho targets, which 
are homologous to human p160 ROCK. The sequences of 
these protein kinases how much higher homology with mouse 
ROCK-II than mouse ROCK-I, although the reported rat 
sequence does not contain the segment corresponding to the 
amino-terminal region of ROCK-II. These rat and bovine 
kinases are, therefore, counterparts of mouse ROCK-II, while 
human p160 ROCK is a counterpart of mouse ROCK-I. In 
addition, Northern blotting analysis on the human tissue dem- 
onstrated that the probes for ROCK-I or ROCK-II detected 
distinct transcripts with different sizes (Nakagawa et al., un- 
published observations). Taken together, we can conclude that 
there are at least two ROCK isoforms in a single species. 
As presented in Fig. 3, the gene expression of mouse 
ROCK-I and ROCK-II  is differentially regulated in mouse 
tissues. A single mRNA band of ROCK-I was detected except 
in the testis, while three major transcripts of ROCK-II were 
expressed. It remains an open question whether this is due to 
alternative splicing or multiplicity of polyadenylation sites. As 
the length and radioactivity of the cDNA probes were ap- 
proximately the same, the mRNA abundance of ROCK-I 
and ROCK-II  could be compared in each tissue. ROCK-I 
mRNA is preferably expressed in the liver, spleen, kidney 
and testis. In contrast, ROCK-II mRNA is predominant in 
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Fig. 3. Tissue distribution of mRNA for mouse ROCK-I and ROCK-II. Northern blotting analyses of mouse ROCK-I (A) and mouse ROCK- 
II (B) were performed. Detected transcripts are shown by arrows, and positions of RNA size markers are shown on the right (in kb). Rehybri- 
dization with a rat GAPDH cDNA probe was carried out, and results are shown as an internal control at the bottom. 
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other tissues, especially in the brain and skeletal muscle. These 
findings raise the possibility that ROCK-I  and ROCK-I I  may 
play distinct roles in a tissue-specific manner. 
In summary, we have identified two isoforms of Rho-asso- 
ci~ted protein kinase, ROCK. The present study will facilitate 
our understanding of the molecular mechanisms of multiple 
Rho functions. 
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